About US
Contact us
-
With Lemtrada's EU nod, Sanofi preps for dual MS drug launchesSanofi now has not one, but two bigmultiple sclerosislaunches to get under way in Europe. Two weeks after nabbing EU approval for its new MS pillAubagio, Sanofi ($SNY) got regulatory clearance forLemt2013/9/17
-
Top 10 rheumatoid arthritis drugs 2013Humirais the world's best-selling drug, bringing in $9.6 billion last year. The way drug information specialist EvaluatePharma sees it, AbbVie's ($ABBV) gem is going to remain the world's best selling2013/9/16
-
FDA turbocharges GlaxoSmithKline's bids for new cancer drug usesArzerra dubbed a breakthrough therapy; Mekinist-Tafinlar combo gets priority review With two back-to-back decisions, the FDA is revving up GlaxoSmithKline's ($GSK) cancer prospects. Friday, the agenc2013/9/16
-
Ruling against GSK's Lovaza fish-oil pill puts hurt on competitor AmarinAmarin has been unable to get traction on Vascepa, and price competition could make it harder Poor Amarin ($AMRN) and its still unrealized hopes for its fish oil cholesterol pill,Vascepa. A U.S. appe2013/9/13
-
GlaxoSmithKline's approval streak helps ease scandal painGlaxoSmithKline ($GSK) has been having a year for the record book. And that's not entirely a good thing2013/9/13
-
CFDA Vice Minister Teng Jiacai meets Secretary General of Ministry of Plantation Industries and Commodities of Malaysia and Ambassador of Malaysia to ChinaOn September 10, 2013, Teng Jiacai, Vice Minister of China Food and Drug Administration (CFDA) met with the delegation led by Datin Paduka Nurmala, Secretary General of Ministry of Plantation Industri2013/9/12
-
CFDA Minister Zhang Yong meets Minister of Health, Welfare and Sports of the Netherlands and Ambassador of the Netherlands to ChinaOn September 10, 2013, Zhang Yong, Minister of China Food and Drug Administration (CFDA), met with the delegation led by Edith Schippers, Minister of Health, Welfare and Sports of the Netherland2013/9/12
-
FDA ratchets up requirements on long-acting, extended-release opioidsLabeling must indicate they are for severe pain only; drugmakers must do studies on abuse potential The FDA, under pressure to help curb abuse ofopioid painkillers, has taken yet another step to damp2013/9/11
-
Lilly's warehouse burglar targeted GlaxoSmithKline, tooA burglar who pulled off a bold warehouse theft at an Eli Lilly ($LLY) facility has now admitted that he made off with millions in GlaxoSmithKline ($GSK) products in a previous heist.2013/9/11
-
Bayer's Xarelto faces stepped-up reports of side effects, deathsThe number of side-effect reports onBayer's anticoagulant drugXareltoappears to be increasing, and some doctors are growing wary of using the drug as a standard first-line treatment,the German newspap2013/9/10